Solid Power Inc
For the period ended Mar 31, 2024. Filed May 8, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 8, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1. Financial Statements
Condensed Consolidated Balance Sheets
(in thousands, except par value and number of shares)
| | | | | | | | |
|---|---|---|---|---|---|---|---|
| · · March 31, 2024 · · · · | |||||||
| · (Unaudited) · December 31, 2023 · | |||||||
| Assets | | | | | | | |
| Current Assets · · · | |||||||
| Cash and cash equivalents | | $14,019 | | $34,537 | | ||
| Marketable securities | | | 132,619 | | | 141,505 | |
| Contract receivables | | 10,106 | | 1,553 | | ||
| Contract receivables from related parties | | | 4,152 | | | — | |
| Prepaid expenses and other current assets | | 9,656 | | 5,523 | | ||
| Total current assets | | 170,552 | | 183,118 | | ||
| Long-Term Assets | | | | | | | |
| Property, plant and equipment, net | | 99,593 | | 99,156 | | ||
| Right-of-use operating lease assets, net | | | 7,004 | | | 7,154 | |
| Right-of-use finance lease assets, net | | | 1,030 | | | 1,088 | |
| Investments | | | 232,307 | | | 239,566 | |
| Intangible assets, net | | 1,800 | | 1,650 | | ||
| Prepaid expenses and other assets | | | 3,884 | | | 1,060 | |
| Total long-term assets | | | 345,618 | | | 349,674 | |
| Total assets | | $516,170 | | $532,792 | | ||
| Liabilities and Stockholders’ Equity | | | | | | ||
| Current Liabilities | | | | | | ||
| Accounts payable and other accrued liabilities | | | 7,866 | | | 6,455 | |
| Deferred revenue | | 3,078 | | 1 | | ||
| Deferred revenue from related parties | | | — | | | 828 | |
| Accrued compensation | | 6,267 | | 7,590 | | ||
| Operating lease liabilities | | | 647 | | | 626 | |
| Finance lease liabilities | | | 374 | | | 379 | |
| Total current liabilities | | 18,232 | | 15,879 | | ||
| Long-Term Liabilities | | | | | | | |
| Warrant liabilities | | | 4,728 | | | 4,227 | |
| Operating lease liabilities | | | 7,824 | | | 7,996 | |
| Finance lease liabilities | | 464 | | 552 | | ||
| Deferred revenue | | | 4,716 | | | — | |
| Other liabilities | | 829 | | 803 | | ||
| Total long-term liabilities | | | 18,561 | | | 13,578 | |
| Total liabilities | | | 36,793 | | | 29,457 | |
| Stockholders’ Equity | | | | ||||
| Common Stock, $0.0001 par value; 2,000,000,000 shares authorized; 178,349,557 and 179,010,884 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively | | 18 | | 18 | | ||
| Additional paid-in capital | | 586,343 | | | 588,515 | | |
| Accumulated deficit | | (105,846) | | (84,639) | | ||
| Accumulated other comprehensive loss | | | (1,138) | | | (559) | |
| Total stockholders’ equity | | 479,377 | | 503,335 | | ||
| Total liabilities and stockholders’ equity | | $516,170 | | $532,792 | | ||
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)
(in thousands, except number of shares and per share amounts)
| | | | | | | | |
|---|---|---|---|---|---|---|---|
| · · Three Months Ended March 31, · | |||||||
| · · 2024 · 2023 · | |||||||
| Revenue | | $5,953 | | $3,792 | | ||
| Operating Expenses | | | | | | | |
| Direct costs | | | 4,290 | | | 6,274 | |
| Research and development | | | 18,873 | | 11,648 | | |
| Selling, general and administrative | | | 8,571 | | 7,188 | | |
| Total operating expenses | | | 31,734 | | 25,110 | | |
| Operating Loss | | | (25,781) | | (21,318) | | |
| Nonoperating Income and Expense | | | | | | | |
| Interest income | | | 5,117 | | | 4,835 | |
| Change in fair value of warrant liabilities | | | (501) | | | (2,662) | |
| Interest expense | | | (42) | | (13) | | |
| Total nonoperating income and expense | | | 4,574 | | 2,160 | | |
| Net Loss Attributable to Common Stockholders | | $(21,207) | | $(19,158) | | ||
| Other Comprehensive Income (Loss) | | | (579) | | | 885 | |
| Comprehensive Loss Attributable to Common Stockholders | | $(21,786) | | $(18,273) | | ||
| Basic and diluted loss per share | | $(0.12) | | $(0.11) | | ||
| Weighted average shares outstanding – basic and diluted | | | 180,784,020 | | | 176,934,261 | |
| | | | | | | | |
Condensed Consolidated Statement of Stockholders’ Equity (Unaudited)
(in thousands, except number of shares)
| | | | | | | | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · · Common Stock · · · · · · · · · · · | ||||||||||||||||||
| · · · · · · · · Additional · · Accumulated · · Accumulated Other · · Total Stockholders’ | ||||||||||||||||||
| · Shares · Amount · paid-in capital · deficit · Comprehensive Loss · Equity | ||||||||||||||||||
| Balance as of December 31, 2023 | | | 179,010,884 | | $18 | | $588,515 | | $(84,639) | | $(559) | | $503,335 | |||||
| Net loss | | — | | — | | | — | | (21,207) | | | — | | (21,207) | ||||
| Withholding of employee taxes related to stock-based compensation | | | — | | | — | | | (169) | | | — | | | — | | | (169) |
| Shares of common stock issued for vested RSUs | | | 161,995 | | | — | | | — | | | — | | | — | | | — |
| Stock options exercised | | 2,360,316 | | — | | | 97 | | — | | | — | | 97 | ||||
| Repurchase and retirement of shares of common stock | | | (3,183,638) | | | — | | | (4,963) | | | — | | | — | | | (4,963) |
| Stock-based compensation expense | | — | | — | | | 2,863 | | — | | | — | | 2,863 | ||||
| Unrealized loss on marketable securities | | | — | | | — | | | — | | | — | | | (579) | | | (579) |
| Balance as of March 31, 2024 | | | 178,349,557 | | $18 | | $586,343 | | $(105,846) | | $(1,138) | | $479,377 | |||||
| | | | | | | | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · · Common Stock · · · · · · · · · · · | ||||||||||||||||||
| · · · · · · · · Additional · · Accumulated · · Accumulated Other · · Total Stockholders’ | ||||||||||||||||||
| · Shares · Amount · paid-in capital · deficit · Comprehensive Loss · Equity | ||||||||||||||||||
| Balance as of December 31, 2022 | | | 176,007,184 | | $18 | | $577,603 | | $(19,090) | | $(3,159) | | $555,372 | |||||
| Net loss | | — | | — | | | — | | (19,158) | | | — | | (19,158) | ||||
| Stock options exercised | | 1,679,954 | | — | | | 150 | | — | | | — | | 150 | ||||
| Stock-based compensation expense | | — | | — | | | 2,222 | | — | | | — | | 2,222 | ||||
| Unrealized gain on marketable securities | | | — | | | — | | | — | | | — | | | 885 | | | 885 |
| Balance as of March 31, 2023 | | | 177,687,138 | | $18 | | $579,975 | | $(38,248) | | $(2,274) | | $539,471 | |||||
Condensed Consolidated Statements of Cash Flows (Unaudited)
(in thousands)
| | | | | | | | |
|---|---|---|---|---|---|---|---|
| · · Three Months Ended March 31, · | |||||||
| · 2024 · 2023 · | |||||||
| Cash Flows from Operating Activities · · · · · · | |||||||
| Net loss | | $(21,207) | | $(19,158) | | ||
| Adjustments to reconcile net loss to net cash and cash equivalents from operating activities: | | | | | | | |
| Depreciation and amortization | | | 3,909 | | 2,264 | | |
| Amortization of right-of-use assets | | | 207 | | | 183 | |
| Stock-based compensation expense | | | 2,863 | | 2,222 | | |
| Change in fair value of warrant liabilities | | | 501 | | | 2,662 | |
| Accretion of discounts on other long-term liabilities | | | (4) | | | — | |
| Amortization of premiums and accretion of discounts on marketable securities | | | (2,428) | | | (2,716) | |
| Change in operating assets and liabilities that provided (used) cash and cash equivalents: | | | | | | | |
| Contract receivables | | | (8,553) | | (179) | | |
| Contract receivables from related parties | | | (4,152) | | | 319 | |
| Prepaid expenses and other assets | | | (6,983) | | (1,129) | | |
| Accounts payable and other accrued liabilities | | | 1,290 | | 1,699 | | |
| Deferred revenue | | | 7,794 | | (14) | | |
| Deferred revenue from related parties | | | (828) | | | (3,000) | |
| Accrued compensation | | | (1,323) | | (2,652) | | |
| Operating and finance lease liabilities, short-term | | | (151) | | | (132) | |
| Net cash and cash equivalents used in operating activities | | | (29,065) | | (19,631) | | |
| Cash Flows from Investing Activities | | | | | | | |
| Purchases of property, plant and equipment | | | (4,054) | | (11,581) | | |
| Purchases of marketable securities and investments | | | (61,287) | | (110,636) | | |
| Proceeds from sales of marketable securities | | | 79,134 | | | 101,665 | |
| Purchases of intangible assets | | | (154) | | (125) | | |
| Net cash and cash equivalents provided by (used in) investing activities | | | 13,639 | | (20,677) | | |
| Cash Flows from Financing Activities | | | | | | | |
| Payments of debt | | | — | | (7) | | |
| Proceeds from exercise of stock options | | | 97 | | 150 | | |
| Cash paid for withholding of employee taxes related to stock-based compensation | | | (169) | | | — | |
| Repurchase of shares of common stock | | | (4,914) | | | — | |
| Payments on finance lease liabilities | | | (106) | | | (70) | |
| Net cash and cash equivalents provided by (used in) financing activities | | | (5,092) | | | 73 | |
| | | | | | | | |
| Net decrease in cash and cash equivalents | | | (20,518) | | | (40,235) | |
| Cash and cash equivalents at beginning of period | | | 34,537 | | | 50,123 | |
| Cash and cash equivalents at end of period | | | 14,019 | | | 9,888 | |
| | | | | | | | |
| Cash paid for interest | | $42 | | $13 | | ||
| Accrued capital expenditures | | $954 | | $3,370 | | ||
Notes to Condensed Consolidated Financial Statements (Unaudited)
Note 1 – Nature of Business
Solid Power is developing solid-state battery technology for the EV and other markets. The Company’s planned business model is to sell its electrolyte and to license its cell designs and manufacturing processes.
Note 2 – Significant Accounting Policies
The significant accounting policies followed by the Company are set forth in Note 2 – Significant Accounting Policies to the Company’s financial statements included in the 2023 Form 10-K and are supplemented by the Notes to the Condensed Consolidated Financial Statements (Unaudited) (the “Notes”) included in this Report. The financial statements included in this Report (including the Notes) should be read in conjunction with the 2023 Form 10-K.
Basis of Presentation and Principles of Consolidation
The accompanying unaudited condensed consolidated financial statements of the Company have been prepared on the basis of GAAP. The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect amounts reported in the unaudited condensed consolidated financial statements. Actual results could differ from those estimates. All dollar amounts presented herein are in U.S. dollars and are in thousands, except par value and share and per share amounts.
The accompanying unaudited condensed consolidated financial statements include accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. Additionally, certain prior period amounts have been reclassified to conform to current period presentation in the accompanying unaudited condensed consolidated financial statements.
Recent Accounting Pronouncements
Income taxes
In December 2023, the FASB issued ASU No. 2023-09Income Taxes (Topic 740) Improvements to Income Tax Disclosures. ASU 2023-09 requires companies to disclose, on an annual basis, specific categories in the effective tax rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold. In addition, ASU 2023-09 requires companies to disclose additional information about income taxes paid. ASU 2023-09 will be effective for annual periods beginning January 1, 2025 and will be applied on a prospective basis with the option to apply the standard retrospectively. The Company is evaluating the disclosure impact of ASU 2023-09.
Segment Reporting
In November 2023, the FASB issued ASU No. 2023-07Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. Among other new disclosure requirements, ASU 2023-07 requires companies to disclose significant segment expenses that are regularly provided to the chief operating decision maker, or CODM. ASU 2023-07 will be effective for annual periods beginning on January 1, 2024 and interim periods beginning on January 1, 2025. ASU 2023-07 must be applied retrospectively to all prior periods presented in the financial statements. The Company is evaluating the disclosure impact of ASU 2023-07.
Note 3 – Property, Plant and Equipment
Property, plant and equipment are summarized as follows:
| | | | | | | | |
|---|---|---|---|---|---|---|---|
| · March 31, 2024 · December 31, 2023 · | |||||||
| Commercial production equipment | | $36,223 | | $36,086 | | ||
| Laboratory equipment | | | 10,748 | | | 9,910 | |
| Leasehold improvements | | 59,361 | | 59,109 | | ||
| Furniture and computer equipment | | 4,042 | | 3,915 | | ||
| Construction in progress | | 16,638 | | 13,650 | | ||
| Total cost | | 127,012 | | 122,670 | | ||
| Accumulated depreciation | | (27,419) | | (23,514) | | ||
| Net property and equipment | | $99,593 | | $99,156 | | ||
Depreciation expenses for dedicated laboratory equipment and commercial production equipment are charged to research and development. The other depreciation expenses are included in the Company’s overhead and are allocated across Operating Expenses based on Company personnel costs incurred.
Depreciation expense related to property, plant and equipment are summarized as follows:
| · · · · · · · | |||||
|---|---|---|---|---|---|
| · · Three Months Ended March 31, · | |||||
| · · 2024 · 2023 · | |||||
| Depreciation expense | | $3,905 | | $2,259 | |
The Company expanded its electrolyte production to produce larger quantities of electrolyte material required to feed cell-production lines and continue research and development efforts at SP2. The Company began producing electrolyte at SP2 in 2023.
| | | | | | | | |
|---|---|---|---|---|---|---|---|
| · · March 31, 2024 · · December 31, 2023 · | |||||||
| Construction in progress | | | | | | | |
| SP1 - Capital projects | | $3,404 | | $2,298 | | ||
| SP2 - Increased scale electrolyte production | | | 13,234 | | | 11,352 | |
Note 4 – Intangible Assets
Intangible assets of the Company are summarized as follows:
| | | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · March 31, 2024 · December 31, 2023 · | |||||||||||||
| · · Gross Carrying · · Accumulated · · Gross Carrying · · Accumulated · | |||||||||||||
| · Amount · Amortization · Amount · Amortization · | |||||||||||||
| Intangible assets: | | | | | | | | | | | | | |
| Licenses | | $149 | | $(63) | | $149 | | $(61) | | ||||
| Patents | | | 124 | | | (7) | | | 92 | | | (5) | |
| Patents pending | | 1,561 | | — | | 1,444 | | — | | ||||
| Trademarks | | | 13 | | | — | | | 13 | | | — | |
| Trademarks pending | | 22 | | — | | 18 | | — | | ||||
| Total amortized intangible assets | | $1,869 | | $(70) | | $1,716 | | $(66) | | ||||
Amortization expense for intangible assets is summarized as follows:
| · · · · · · · | |||||
|---|---|---|---|---|---|
| · · Three Months Ended March 31, | |||||
| · · 2024 · 2023 | |||||
| Amortization expense | | $4 | | $5 | |
Useful lives of intangible assets range from three to 20 years. Amortization expenses are allocated ratably across Operating Expenses based on Company personnel costs incurred.
Note 5 – Collaborative Arrangement
On January 10, 2024, the Company entered into the SK On Agreements.
The Company determined the R&D License Agreement, Electrolyte Supply Agreement, and the Line Installation Agreement should be combined and evaluated as a single contract, the SK On Agreements. The SK On Agreements were determined to be a collaborative arrangement in accordance with ASC Topic 808, Collaborative Arrangements, and revenue recognition is recorded by analogy to ASC Topic 606, Revenue from Contracts with Customers. The Company determined the SK On Agreements represent a single, combined performance obligation. Collaborative revenue will be recognized over time using the input measurement method utilizing incurred labor hours in relation to total labor hours anticipated to satisfy the combined performance obligation. The Company will expense contract fulfillment costs as incurred.
Note 6 – Fair Value Measurements
The Company considers all highly liquid instruments with original maturities of less than 90 days to be cash equivalents. The carrying amounts of certain financial instruments, such as cash equivalents, short-term investments, accounts receivable, accounts payable, and accrued liabilities, approximate fair value due to their relatively short maturities.
Assets and Liabilities Measured and Recorded at Fair Value on a Recurring Basis
As of March 31, 2024 and December 31, 2023, the Company’s financial assets and liabilities measured and recorded at fair value on a recurring basis were classified within the fair value hierarchy as follows:
| | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · · March 31, 2024 | ||||||||||||
| | Level 1 | Level 2 | Level 3 | Total | ||||||||
| Assets | | | | | | | | | | | | |
| Commercial Paper | | $95,059 | | $— | | $— | | $95,059 | ||||
| Corporate Bonds | | $223,649 | | $— | | $— | | $223,649 | ||||
| Government Bonds | | $46,218 | | $— | | $— | | $46,218 | ||||
| | | | | | | | | | | | | |
| Liabilities | | | | | | | | | | | | |
| Public Warrants | | $2,637 | | $— | | $— | | $2,637 | ||||
| Private Placement Warrants | | $— | | $2,091 | | $— | | $2,091 | ||||
| | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · · December 31, 2023 | ||||||||||||
| | Level 1 | Level 2 | Level 3 | Total | ||||||||
| Assets | | | | | | | | | | | | |
| Commercial Paper | | $84,909 | | $— | | $— | | $84,909 | ||||
| Corporate Bonds | | $239,473 | | $— | | $— | | $239,473 | ||||
| Government Bonds | | $56,689 | | $— | | $— | | $56,689 | ||||
| | | | | | | | | | | | | |
| Liabilities | | | | | | | | | | | | |
| Public Warrants | | $2,505 | | $— | | $— | | $2,505 | ||||
| Private Placement Warrants | | $— | | $1,722 | | $— | | $1,722 | ||||
The change in fair value of the Company’s marketable securities and long-term investments are included in other comprehensive income (loss). There wereno transfers in and out of Level 3 fair value hierarchy during the three months ended March
31, 2024 or year ended December 31, 2023. During the three months ended March 31, 2024 and 2023, the Company purchased$61,287 and$110,636 of marketable securities and long-term investments, respectively.
Fair Value of Warrants
The fair value of the Private Placement Warrants have been estimated using a Black-Scholes model as of March 31, 2024 and December 31, 2023 Consolidated Balance Sheet dates. The estimated fair value of the Private Placement Warrants is determined using Level 2 directly or indirectly observable inputs. Inherent in a Black-Scholes model are assumptions related to expected stock-price volatility, expected life, risk-free interest rate, and dividend yield. Material increases (or decreases) in any of those inputs may result in a significantly higher (or lower) fair value measurement. The Company estimates the volatility of its Private Placement Warrants based on implied volatility from the Company’s Public Warrants and from historical volatility of select peer companies’ common stock. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve for a maturity similar to the expected remaining life of the Warrants. The dividend yield is based on the historical rate, which the Company anticipates remaining at zero. The fair value of the Public Warrants has been measured based on the quoted price of such warrants on the Nasdaq Stock Market, a Level 1 input.
The following table provides quantitative information regarding Level 2 inputs used in the recurring valuation of the Private Placement Warrants as of their measurement dates:
| · · · · · · · | |||||
|---|---|---|---|---|---|
| · March 31, 2024 · December 31, 2023 | |||||
| Exercise price | | $11.50 | | $11.50 | |
| Stock price | | $2.03 | | $1.45 | |
| Volatility | | 85.8% | 95.0% | ||
| Term (in years) | | 2.69 | | 2.94 | |
| Risk-free rate | | 4.36% | 3.94% | ||
The following table provides a rollforward of the Public Warrants measured at fair value per Public Warrant using Level 1 inputs and Private Placement Warrants measured at fair value per Private Placement Warrant using Level 2 inputs:
| · · · · · · | ||||
|---|---|---|---|---|
| | | Public Warrants | | Private Placement Warrants |
| · Level 1 Fair Value · Level 2 Fair Value | ||||
| December 31, 2023 | | $0.19 | | $0.28 |
| Change in fair value | | $0.01 | | $0.06 |
| March 31, 2024 | | $0.20 | | $0.34 |
The following tables provides a reconciliation of the change in fair value for the Public Warrants and Private Placement Warrants at March 31.
| · · · · · · · · · · · · · | ||||||||
|---|---|---|---|---|---|---|---|---|
| · · · · · · · · Three Months Change in · · | ||||||||
| Warrant Class · Level · Warrants · December 31, 2023 · Fair Value · March 31, 2024 | ||||||||
| Public Warrants | 1 | 13,182,501 | | $2,505 | | $132 | | $2,637 |
| Private Placement Warrants | 2 | 6,150,802 | | $1,722 | | $369 | | $2,091 |
| Total | 19,333,303 | | $4,227 | | $501 | | $4,728 | |
Note 7 – Warrant Liabilities
The table below provides a summary of the outstanding Public and Private Placement Warrants at:
| | | | | |
|---|---|---|---|---|
| · March 31, 2024 · December 31, 2023 | ||||
| Public Warrants | | 13,182,501 | | 13,182,501 |
| Private Placement Warrants | | 6,150,802 | | 6,150,802 |
Each whole Warrant entitles the holder thereof to purchaseone share of common stock at a price of$11.50 per share, subject to customary adjustments. Only whole Warrants are exercisable. The Warrants became exercisable on January 7, 2022 and will expire on December 8, 2026.
None of the Private Placement Warrants are redeemable by the Company so long as they are held by the initial purchasers of the Private Placement Warrants or their permitted transferees. The table below provides the fair value of warrant liabilities at:
| · · · · · · | ||||
|---|---|---|---|---|
| | | March 31, 2024 | | December 31, 2023 |
| Fair value of warrant liabilities | | $4,728 | | $4,227 |
The table below provides the Company’s loss recognized in connection with changes in fair value of warrant liabilities:
| · · · · · · · | |||||
|---|---|---|---|---|---|
| · · · Three Months Ended March 31, | |||||
| · · 2024 · 2023 | |||||
| Loss recognized associated with warrant liabilities | | $(501) | | $(2,662) | |
There have been no changes to our Public or Private Placement Warrants, including redemption terms disclosed in our 2023 Form 10-K.
Note 8 – Stockholders’ Equity
Common Stock
Stock options exercised for common stock, shares of common stock repurchased under the stock repurchase program, and shares of common stock issued upon vesting of RSUs for the three months ended March 31, 2024 and 2023 are summarized in the table below:
| | | | | | |
|---|---|---|---|---|---|
| · · Three Months Ended March 31, · | |||||
| · · 2024 · 2023 · | |||||
| Stock options exercised | | 2,360,316 | | 1,679,954 | |
| Shares of common stock repurchased | | (3,183,638) | | — | |
| Shares of common stock issued for vested RSUs | | 161,995 | | — | |
The table below presents the cash received or paid associated with common stock related activities for the three months ended March 31, 2024 and 2023:
| | | | | | | |
|---|---|---|---|---|---|---|
| · · · Three Months Ended March 31, | ||||||
| · · 2024 · · 2023 | ||||||
| Cash received from stock options exercised | | $97 | | $150 | ||
| Cash paid for shares of common stock repurchased | | | (4,914) | | | — |
Stock Repurchase Program
On January 23, 2024, the Company announced that its Board approved a stock repurchase program authorizing the Company to purchase up to$50,000 of the Company’s outstanding common stock. Under the repurchase program, the Company may purchase shares of its common stock from time to time until the repurchase program expires on December 31, 2025.
The table below presents the number of shares repurchased and retired, the aggregate cost, and the average purchase price per share for the three months ended March 31, 2024:
| · · · · · · · · · | |||||||
|---|---|---|---|---|---|---|---|
| | | Shares | | | Aggregate cost | | Avg. Price Paid Per Share |
| Repurchased and retired shares of common stock | | | 3,183,638 | | $4,963 | | $1.52 |
In April 2024, the Company purchased 1,816,362 shares of common stock for$3,393 with an average price of$1.85 per share, under the stock repurchase program.
Note 9 – Stock-Based Compensation
There have been no changes to our equity incentive plans, the ESPP, or our accounting methodology for stock-based compensation, as disclosed in our 2023 Form 10-K.
The fair value of stock options and RSUs issued to employees and directors is recognized as compensation expense over the period of service that generally coincides with the vesting period of the award. The Company allocated compensation ratably across Operating Expenses based on Company personnel costs incurred. When calculating the amount of annual compensation expense, the Company has elected not to estimate forfeitures and instead accounts for forfeitures as they occur.
For the three months ended March 31, 2024 and 2023, the Company recognized compensation costs totaling:
| | | | | | | |
|---|---|---|---|---|---|---|
| · · Three Months Ended March 31, | ||||||
| · · 2024 · 2023 | ||||||
| Equity-based compensation costs related to RSUs | | $1,212 | | $635 | ||
| Equity-based compensation costs related to stock options | | 1,614 | | 1,587 | ||
| Equity-based compensation costs related to ESPP | | | 37 | | | — |
| Total equity-based compensation costs | | $2,863 | | $2,222 | ||
| Unrecognized future compensation cost as of: | | | 20,837 | | | 59,945 |
The following table summarizes our award activity for RSUs and stock options for the three months ended March 31, 2024:
| | | | | | |
|---|---|---|---|---|---|
| · · · | |||||
| · · RSUs · · Stock Options | |||||
| Balance at December 31, 2023 | | 4,473,016 | | 24,264,016 | |
| Granted | | 3,159,872 | | | 4,566,167 |
| Vested or Exercised | | (264,754) | | | (2,360,316) |
| Forfeited | | (72,619) | | | (842,395) |
| Balance at March 31, 2024 | | 7,295,515 | | | 25,627,472 |
Stock Options
The fair value of each stock option grant during the three months ended March 31, 2024 and 2023 was estimated on the grant date using the Black-Scholes option pricing model with the following weighted-average assumptions used:
| | | | | | | | | |
|---|---|---|---|---|---|---|---|---|
| · Three Months Ended March 31, · | ||||||||
| · 2024 · 2023 · | ||||||||
| Approximate risk‑free rate | | 4.21% | | 4.28% | | |||
| Volatility | | 48.35% | | 46.86% | | |||
| Average expected life (in years) | | 6 | | | 6 | | | |
| Dividend yield | | —% | | —% | | |||
| Weighted‑average grant date fair value | | $1.56 | | $3.11 | | | ||
| Estimated fair value of total stock options granted | | $3,675 | | $5,165 | | | ||
Note 10 – Basic and Diluted Loss Per Share
Basic loss per share represents net loss attributable to common stock divided by the basic weighted average number of shares of common stock outstanding during the period.
Diluted loss per share also includes the dilutive effect of additional potential shares of common stock issuable from stock-based awards determined using the treasury stock method. Diluted loss per share represents net earnings divided by diluted weighted average number of shares of common stock, which includes the average dilutive effect of all potentially dilutive securities that are outstanding during the period.
The table below sets forth the basic and diluted loss per share calculation for the three months ended March 31, 2024 and 2023.
| | | | | | | | |
|---|---|---|---|---|---|---|---|
| · · Three Months Ended March 31, · | |||||||
| · · 2024 · · 2023 · | |||||||
| Net loss attributable to common stockholders | | $(21,207) | | $(19,158) | | ||
| Weighted average shares outstanding – basic and diluted | | | 180,784,020 | | | 176,934,261 | |
| Basic and diluted loss per share | | $(0.12) | | $(0.11) | | ||
Due to the net loss for the three months ended March 31, 2024 and 2023 presented above, diluted loss per share was computed without consideration to potentially dilutive instruments as their inclusion would have been anti-dilutive. The table below sets forth (in shares) potentially dilutive securities excluded from the diluted loss per share calculation for the three months ended March 31, 2024 and 2023.
| | | | | | |
|---|---|---|---|---|---|
| · · Three Months Ended March 31, · | |||||
| · · 2024 · 2023 · | |||||
| Warrants | | 19,333,303 | 19,333,303 | | |
| 2014 Plan & 2021 Plan - Stock Options | | 22,140,322 | 25,352,980 | | |
| 2021 Plan - RSUs | | 5,031,773 | 1,764,062 | | |
| ESPP - Common Stock | | 184,970 | | 90,314 | |
| Contingently Issued Shares of Common Stock | | — | | 49,834 | |
| Total potentially dilutive securities | | 46,690,368 | | 46,590,493 | |
Note 11 – Leases
The Company leases its facilities and certain equipment. Fixed rent escalates each year, and the Company is responsible for a portion of the landlords’ operating expenses such as property tax, insurance, and common area maintenance.
The Company’s facility in Louisville, Colorado, is under a noncancelable operating lease with a maturity date in September 2029. In 2022, the Company amended this operating lease to incorporate a prior subleased space into the base lease and extend the term of the lease. The Company has the right to renew this operating lease for an additional five-year period.
On September 1, 2021, the Company entered into an industrial operating lease agreement for its facility in Thornton, Colorado, with the initial term through March 31, 2029. Under this operating lease, the Company has one option to renew forfive years, which has been included in the calculation of lease liabilities and right-of-use assets at the adoption date of the lease accounting standard on January 1, 2022, as the exercise of the option was reasonably certain. As the renewal rent has not been negotiated, the Company used an estimated rent rate which approximated the fair market rent at adoption of ASC 842 on January 1, 2022 for the extension period.
The Company has certain equipment leases classified as finance leases as of March 31, 2024.
The Company’s leases do not have any contingent rent payments and do not contain residual value guarantees.
The components of lease expense are as follows:
| · · · · | |||
|---|---|---|---|
| · Three Months Ended · | |||
| · March 31, 2024 · | |||
| Finance lease costs: | | | |
| Amortization of right-of-use assets | | $58 | |
| Interest on lease liabilities | | 14 | |
| Operating lease costs | | 290 | |
| Total lease expense | | $362 | |
The components of cash flow information related to leases are as follows:
| | | | | |
|---|---|---|---|---|
| · Three Months Ended · | ||||
| · March 31, 2024 · | ||||
| Operating outgoing cash flows – finance leases | | $14 | | |
| Financing outgoing cash flows – finance leases | | 92 | | |
| Operating outgoing cash flows – operating leases | | 292 | | |
| Right-of-use assets obtained in exchange for new finance lease liabilities: | | | — | |
| Right-of-use assets obtained in exchange for new operating lease liabilities: | | | — | |
| · · · | ||
|---|---|---|
| · March 31, 2024 | ||
| Finance lease · | ||
| Weighted-average remaining lease term – finance leases (in years) | 2.64 | |
| Weighted-average discount rate – finance leases | 6.5% | |
| Operating lease | | |
| Weighted-average remaining lease term – operating leases (in years) | 8.99 | |
| Weighted-average discount rate – operating leases | 6.8% | |
As of March 31, 2024, future minimum payments during the next five years and thereafter are as follows:
| | | | | | | |
|---|---|---|---|---|---|---|
| Fiscal year · Finance Lease · Operating Lease | ||||||
| 2024 (remaining nine months) | | $319 | | $881 | ||
| 2025 | | | 310 | | | 1,210 |
| 2026 | | | 179 | | | 1,248 |
| 2027 | | | 85 | | | 1,288 |
| 2028 | | | 16 | | | 1,329 |
| 2029 | | | — | | | 1,211 |
| Thereafter | | | — | | | 4,031 |
| Total | | | 909 | | | 11,198 |
| Less present value discount | | | (71) | | | (2,728) |
| Total lease liabilities | | $838 | | $8,470 | ||
Note 12 – Related Party Transactions
During the three months ended March 31, 2024, the Company recognized$4,980 of revenue related to the BMW JDA. As of March 31, 2024, the Company recorded$4,152 of accounts receivable related to the BMW JDA. During the three months ended March 31, 2023, the Company recognized$3,000 of revenue related to the BMW JDA. For the year ended, December 31, 2023, the Company recorded$828 of deferred revenue related to cash paid from BMW in advance of services provided.
Note 13 – Income Taxes
The Company’s effective tax rate was 0.00% and the Company was in a full valuation allowance for the three months ended March 31, 2024 and 2023.
Note 14 – Contingencies
In the normal course of business, the Company may be party to litigation from time to time. The Company maintains insurance to cover certain actions and believes that resolution of such litigation will not have a material adverse effect on the Company.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.